SPOTLIGHT -
Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis
Jing Han, MD, and colleagues examine the prevalence and characteristics of ocular toxicities associated with MEK inhibition.